在与代谢功能障碍相关的脂肪性肝病中,MRPL44通过BNIP3介导的线粒细胞衰变来调节脂质代谢

Siqi Liu1, Lianggui Xiao2, Qiuchen Cheng1

  • 1Institute of Digestive Disease, Guangxi Academy of Medical Sciences, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.

Frontiers in nutrition
|October 20, 2025
PubMed
概括

线性与代谢功能障碍相关的脂肪性肝病作斗争. 这项研究揭示了MRPL44蛋白通过增强甲状腺食来减轻肝脏脂肪的积累,提供了一个新的治疗点.